IP Library Granted Patent US 8,226,814
Granted Patent B2
US 8,226,814 · App. 12/102,749 · Granted Jul 24, 2012

Transition metal complexes with pyridyl-imidazole ligands

Assignee: Abbott Diabetes Care Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,226,814
App. No.
12/102,749
Granted
Jul 24, 2012
Kind
B2
Abstract

Enzyme-based electrochemical sensors comprising transition metal complexes of iron, cobalt, ruthenium, osmium, and vanadium are described. The transition metal complexes can be used as redox mediators and include substituted or unsubstituted pyridyl-imidazole ligands. Transition metal complexes attached to polymeric backbones are also described.

Claims (80)

1. A test strip comprising:

a working electrode; and

a counter electrode;

wherein the working electrode comprises:

a transition metal complex having the formula:

wherein c is a negative, neutral, or positive charge represented by −1 to −5, 0, or +1 to +5, inclusive, respectively;

d is a number of counter ions, X, from 0 to 5, inclusive;

M is cobalt, iron, osmium, ruthenium, or vanadium;

L 1 has the formula:

wherein R 11 , R 12 , R 14 and R 15 are independently —H, —F, —C1, —Br, —I, —NO 2 , —CN, —CO 2 H, —OH, —NH 2 , alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxyamino, alkylthio, alkenyl, aryl, or alkyl and R 13 is a C1-C2 alkylamino;

L 2 is a negatively charged ligand; and

L and L′ are independently:

wherein R′ 1 is a substituted or an unsubstituted alkyl, alkenyl or aryl;

each of R a and R b is independently —H, —F, —C1, —Br, —I, —NO 2 , —CN, —CO 2 H, —S0 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxylamino, alkylthio, alkenyl, aryl, or alkyl;

each of R c and R d is independently —H, —F, —C1, —Br, —I, —NO 2 , —CN, —CO 2 H, —S0 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylarninocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylarnino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxyfamino, alkoxylarnino, alkylthio, alkenyl, aryl, or alkyl, or a combination of Rc and Rd forms a saturated or an unsaturated 5- or 6-membered ring; and

each of R′ 3 and R′ 4 is independently —H, —F, —C1, —Br, —I, —NO 2 , —CN, —CO 2 H, —S0 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxylamino, alkylthio, alkenyl, aryl, or alkyl, or a combination of R′ 3 and R′ 4 forms a saturated or an unsaturated 5- or 6-membered ring; and

a dehydrogenase.

2. The test strip of claim 1 , wherein the dehydrogenase is a PQQ-dependent dehydrogenase.

3. The test strip of claim 1 , wherein M is osmium.

4. The test strip of claim 1 , wherein R 13 is a C1 alkylamino.

5. A test strip comprising:

a working electrode; and

a counter electrode;

wherein the working electrode comprises:

a transition metal complex having the formula:

wherein c is a negative, neutral, or positive charge represented by −1 to −5, 0, or +1 to +5, inclusive, respectively;

d is a number of counter ions, X, from 0 to 5, inclusive;

M is cobalt, iron, osmium, ruthenium, or vanadium;

L 1 has the formula:

wherein R 11 , R 12 , R 14 and R 15 are independently —H, —F, —C1, —Br, —I, —NO 2 , —CN, —CO 2 H, —OH, —NH 2 , alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxyamino, alkylthio, alkenyl, aryl, or alkyl and R 13 is a C1-C2 alkoxy;

L 2 is a negatively charged ligand; and

L and L′ are independently:

wherein R′ 1 is a substituted or an unsubstituted alkyl, alkenyl or aryl;

each of R a and R b is independently —H, —F, —C1, —Br, —I, —NO 2 , —CN, —CO 2 H, —S0 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxylamino, alkylthio, alkenyl, aryl, or alkyl;

each of R c and R d is independently —H, —F, —C1, —Br, —I, —NO 2 , —CN, —CO 2 H, —S0 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylarninocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylarnino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxyfamino, alkoxylarnino, alkylthio, alkenyl, aryl, or alkyl, or a combination of Rc and Rd forms a saturated or an unsaturated 5- or 6-membered ring; and

each of R′ 3 and R′ 4 is independently —H, —F, —C1, —Br, —I, —NO 2 , —CN, —CO 2 H, —S0 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxylamino, alkylthio, alkenyl, aryl, or alkyl, or a combination of R′ 3 and R′ 4 forms a saturated or an unsaturated 5- or 6-membered ring; and

a dehydrogenase.

6. The test strip of claim 5 , wherein the dehydrogenase is a PQQ-dependent dehydrogenase.

7. The test strip of claim 5 , wherein M is osmium.

8. The test strip of claim 5 , wherein R 13 is a C1 alkoxy.

9. A method for monitoring the concentration of an analyte in a biological fluid, the method comprising:

applying a sample containing the analyte to an electrochemical sensor, the electrochemical sensor comprising:

a working electrode, wherein the working electrode comprises a transition metal complex having the formula:

wherein c is a negative, neutral, or positive charge represented by −1 to −5, 0, or +1 to +5, inclusive, respectively;

d is a number of counter ions, X, from 0 to 5, inclusive;

M is cobalt, iron, osmium, ruthenium, or vanadium;

L 1 has the formula:

wherein R 11 , R 12 , R 14 and R 15 are independently —H, —F, —C1, —Br, —I, —NO 2 , —CN, —CO 2 H, —OH, —NH 2 , alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxyamino, alkylthio, alkenyl, aryl, or alkyl and R 13 is a C1-C2 alkylamino;

L 2 is a negatively charged ligand; and

L and L′ are independently:

wherein R′ 1 is a substituted or an unsubstituted alkyl, alkenyl or aryl;

each of R a and R b is independently —H, —F, —C1, —Br, —I, —NO 2 , —CN, —CO 2 H, —S0 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxylamino, alkylthio, alkenyl, aryl, or alkyl;

each of R c and R d is independently —H, —F, —C1, —Br, —I, —NO 2 , —CN, —CO 2 H, —S0 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylarninocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylarnino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxyfamino, alkoxylarnino, alkylthio, alkenyl, aryl, or alkyl, or a combination of Rc and Rd forms a saturated or an unsaturated 5- or 6-membered ring; and

each of R′ 3 and R′ 4 is independently —H, —F, —C1, —Br, —I, —NO 2 , —CN, —CO 2 H, —S0 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxylamino, alkylthio, alkenyl, aryl, or alkyl, or a combination of R′ 3 and R′ 4 forms a saturated or an unsaturated 5- or 6-membered ring; and

a dehydrogenase; and

a counter electrode; and

determining the concentration of an analyte in the sample.

10. The method of claim 9 , wherein the dehydrogenase is a PQQ-dependent dehydrogenase.

11. The method of claim 9 , wherein the analyte is glucose.

12. The method of claim 9 , wherein R 13 is a C1 alkylamino.

13. A method for monitoring the concentration of an analyte in a biological fluid, the method comprising:

applying a sample containing the analyte to an electrochemical sensor, the electrochemical sensor comprising:

a working electrode, wherein the working electrode comprises a transition metal complex having the formula:

wherein c is a negative, neutral, or positive charge represented by −1 to −5, 0, or +1 to +5, inclusive, respectively;

d is a number of counter ions, X, from 0 to 5, inclusive;

M is cobalt, iron, osmium, ruthenium, or vanadium;

L 1 has the formula:

wherein R 11 , R 12 , R 14 and R 15 are independently —H, —F, —C1, —Br, —I, —NO 2 , —CN, —CO 2 H, —OH, —NH 2 , alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxyamino, alkylthio, alkenyl, aryl, or alkyl and R 13 is a C1-C2 alkoxy;

L 2 is a negatively charged ligand; and

L and L′ are independently:

wherein R′ 1 is a substituted or an unsubstituted alkyl, alkenyl or aryl;

each of R a and R b is independently —H, —F, —C1, —Br, —I, —NO 2 , —CN, —CO 2 H, —S0 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxylamino, alkylthio, alkenyl, aryl, or alkyl;

each of R c and R d is independently —H, —F, —C1 , —Br, —I, —NO 2 , —CN, —CO 2 H, —S0 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylarninocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylarnino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxyfamino, alkoxylarnino, alkylthio, alkenyl, aryl, or alkyl, or a combination of Rc and Rd forms a saturated or an unsaturated 5- or 6-membered ring; and

each of R′ 3 and R′ 4 is independently —H, —F, —C1 , —Br, —I, —NO 2 , —CN, —CO 2 H, —S0 3 H, —NHNH 2 , —SH, —OH, —NH 2 , or substituted or unsubstituted alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxy, alkylamino, dialkylamino, alkanoylamino, arylcarboxamido, hydrazino, alkylhydrazino, hydroxylamino, alkoxylamino, alkylthio, alkenyl, aryl, or alkyl, or a combination of R′ 3 and R′ 4 forms a saturated or an unsaturated 5- or 6-membered ring; and

a dehydrogenase; and

a counter electrode; and

determining the concentration of an analyte in the sample.

14. The method of claim 13 , wherein the dehydrogenase is a PQQ-dependent dehydrogenase.

15. The method of claim 13 , wherein the analyte is glucose.

16. The method of claim 13 , wherein R 13 is a C1 alkoxy.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2008
From: OUYANG, TIANMEI; LIU, ZENGHE; LATOUR, JOHN; CHEN, TING; TRAN, LAM N.; FELDMAN, BENJAMIN; MAO, FEI; HELLER, ADAM
To: ABBOTT DIABETES CARE INC.
Reel/Frame 021189/0869 →
Continuity (6)
Continuation In Part 11933219 · Oct 31, 2007
Continuation In Part 11361427 · Feb 24, 2006
Continuation 10714835 · Nov 14, 2003
Continuation 10143300 · May 9, 2002
Provisional Application 60290537 · May 11, 2001
Related Publication 20090095642A1 · Apr 16, 2009